United States Diabetes Care Devices Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

Read more about this report - Request a Free Sample

United States Diabetes Care Devices Market Overview

Diabetes care devices continue to advance through innovations that improve glucose monitoring, insulin delivery, and overall disease management. Increasing adoption of connected technologies is supporting better treatment outcomes and enhancing patient convenience. The market is driven by the high prevalence of diabetes, widespread adoption of advanced monitoring systems, favorable reimbursement policies, and continuous product innovation. The market is poised to grow at a CAGR of 11.80% during the forecast period of 2026-2035.

United States Diabetes Care Devices Market Growth Analysis and Key Influencers

United States Diabetes Care Devices Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

United States Diabetes Care Devices Market Growth Drivers

Expanding Access to Continuous Glucose Monitoring Technologies Strengthens the Market Value

The increasing availability of advanced continuous glucose monitoring devices is accelerating the adoption of diabetes care technologies across the market. Wider access to user-friendly and non-prescription monitoring solutions enables earlier glucose tracking, improves disease management, and supports better long-term health outcomes. For instance, in June 2026, the U.S. Food and Drug Administration (FDA) cleared Dexcom's Stelo Glucose Biosensor System as the first over-the-counter CGM for children aged two years and older who do not use insulin, expanding pediatric access to real-time glucose monitoring. This regulatory advancement is expected to further strengthen the market by broadening the adoption of innovative diabetes care devices.

United States Diabetes Care Devices Market Restraints

Product Recalls and Device Accuracy Concerns Limit Market Growth

Concerns regarding device accuracy and product reliability continue to challenge the market by affecting consumer confidence and adoption. Incorrect glucose readings can lead to inappropriate treatment decisions, increasing safety risks and reducing trust in diabetes monitoring technologies. For example, in December 2025, the U.S. Food and Drug Administration (FDA) warned consumers to discontinue the use of certain Abbott FreeStyle Libre 3 and Libre 3 Plus sensors after reports of inaccurate low glucose readings associated with serious adverse events. Such incidents highlight the importance of product reliability and may temporarily restrain market expansion.

United States Diabetes Care Devices Market Opportunities

Advancements in Multi-Parameter Biosensing Technologies Create New Market Potential

The development of next-generation diabetes monitoring technologies that integrate multiple biomarkers is creating significant expansion potential for the market. These innovations improve disease management by providing more comprehensive health insights while supporting early intervention for diabetes-related complications. For example, in May 2026, Abbott announced CE Mark approval for its Libre Duo system, the world's first continuous glucose and ketone monitoring sensor, enabling real-time monitoring of both biomarkers through a single wearable device. Such technological advancements are expected to broaden future applications and create new growth opportunities across the market.

United States Diabetes Care Devices Market Trends

The market is witnessing several trends, including AI-enabled diabetes management and advanced digital glucose monitoring technologies.

Growing Integration of Artificial Intelligence in Diabetes Management Is Expected to Enhance Market Landscape

The integration of artificial intelligence with continuous glucose monitoring platforms is transforming diabetes management by delivering personalized health insights and supporting earlier disease detection. For example, in July 2026, Dexcom became the first participant selected for the U.S. Food and Drug Administration's TEMPO Digital Health Devices Pilot Program to evaluate an AI-powered glucose health platform integrating glucose, nutrition, physical activity, sleep, and stress data. This trend is expected to accelerate digital innovation and support sustained market growth.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Read more about this report - Request a Free Sample

United States Diabetes Care Devices Market Share

Type 2 Diabetes Segment Is Expected to Lead the Market by Disease Type

The market is segmented by disease type into Type 1 Diabetes and Type 2 Diabetes. Among these, Type 2 Diabetes is expected to account for the largest market share due to its substantially higher prevalence and the growing need for continuous disease monitoring and long-term glucose management. According to the Centers for Disease Control and Prevention (CDC), more than 40 million Americans have diabetes, with 90% to 95% diagnosed with Type 2 diabetes. The expanding patient population continues to increase demand for advanced diabetes care devices, reinforcing the leadership of this segment throughout the forecast period.

Leading Players in the United States Diabetes Care Devices Market

United States Diabetes Care Devices Market Segmentation

Key Questions Answered in the United States Diabetes Care Devices Market Report

• What was the United States diabetes care devices market value in 2025?
• What is the United States diabetes care devices market forecast outlook for 2026-2035?
• What are the major factors aiding the United States diabetes care devices market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major diabetes care devices market trends?
• Which product type is expected to dominate the market segment?
• Which disease type is projected to lead the market segment?
• Which patient care settings are likely to dominate the market segment?
• Who are the key players involved in the United States diabetes care devices market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a robust mixed-methods research design combining:

• Primary Research: In-depth interviews conducted with 30+ endocrinologists, diabetologists, certified diabetes care and education specialists (CDCES), diabetes clinic administrators, medical device procurement managers, and reimbursement experts across the United States, including key opinion leaders (KOLs) affiliated with the American Diabetes Association (ADA), Association of Diabetes Care & Education Specialists (ADCES), and leading academic medical centers.
• Secondary Research: Peer-reviewed publications from Diabetes Care, The Lancet Diabetes & Endocrinology, and JAMA; regulatory documents from the U.S. Food and Drug Administration (FDA); epidemiological data from the Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH); clinical trial data from ClinicalTrials.gov; and product portfolios, annual reports, investor presentations, press releases, and regulatory updates from company websites of Abbott, Dexcom, Medtronic, Insulet, Roche, Ascensia Diabetes Care, and other leading market participants.
• Validation: All quantitative estimates are triangulated using top-down and bottom-up market modeling and validated through iterative expert review and industry feedback.